Lv3
210 积分 2025-02-05 加入
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
18天前
已完结
Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification
1个月前
已完结
Unicorns, dragons, antisynthetase-negative antisynthetase syndrome, and other mythologic beasts
1个月前
已完结
Lions, sharks, antisynthetase syndrome, and other real world beasts
1个月前
已完结
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project
1个月前
已完结
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
1个月前
已完结
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: a phase Ib, randomized, double-blind, placebo-controlled study
1个月前
已完结
Beyond muscle strength: functional performance measures enhance assessment of disease activity in juvenile dermatomyositis
3个月前
已关闭
A Phase 3 Trial of Brepocitinib in Dermatomyositis
3个月前
已完结
Immune-mediated inflammatory disease therapeutics: past, present and future
5个月前
已完结
皖公网安备34019202002308
